Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
Rachael L DiSantostefano,1 Hao Li,1 David Hinds,1 Dmitry V Galkin,2 David B Rubin21Worldwide Epidemiology, 2Respiratory Clinical Development, GlaxoSmithKline, Research Triangle Park, Durham, NC, USABackground: Pneumonia poses a significant risk in patients with moderate to severe chronic obstructiv...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-05-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/risk-of-pneumonia-with-inhaled-corticosteroidlong-acting-beta2-agonist-a16714 |